Crinetics Pharma: FDA Approves PALSONIFY, First Daily Pill For Acromegaly
26/9 03:33
(RTTNews) - Crinetics Pharmaceuticals Inc. (CRNX) announced that the U.S. Food and Drug Administration has approved PALSONIFY (paltusotine) as a first-line treatment for adults with acromegaly who have not responded adequately to surgery or for whom surgery is not an option....